Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire. This is the biggest overseas acquisition by a Japanese company. Takeda will also become one of the most indebted after the deal. In addition to issuing new shares, the company has secured $30.9 billion in bank loans. The acquisition is expected to close on January 8.